Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277887 · ClinicalTrials.gov registry record · NA
Smoking Cessation for Smokers With Sleep Problems
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01277887: Completed NA study, sponsored by Yale University.
NCT01277887 is a NA study that has completed, run by Yale University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01277887, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is a pilot research study examining two types of behavioral counseling along with the nicotine patch for smoking cessation. The study is designed to find out whether one of these counseling interventions is more effective for smoking cessation among individuals with sleep problems. The study has three parts: 1) an intake session; 2) a 10-week treatment phase, and 3) a 1-month follow-up.
Primary Outcome
Smoking abstinence is operationally defined as "no smoking on the last 7 days of the last week of treatment. And no smoking within the last 7 days at the first follow-up visit 4 weeks after completing treatment."
Interventions
- BEHAVIORAL Smoking Cessation Counseling
- BEHAVIORAL Cognitive-Behavioral Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01277887 record still lists
NCT01277887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Smoking Cessation Counseling is the first listed.
NCT01277887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01277887 about?
NCT01277887 is a clinical study titled "Smoking Cessation for Smokers With Sleep Problems". This is a pilot research study examining two types of behavioral counseling along with the nicotine patch for smoking cessation. The study is designed to find out whether one of these counseling interventions is more effective for smoking cessation among individuals with sleep problems. The study ha...
What is the current status of trial NCT01277887?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2010-12. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01277887?
The interventions under investigation include: Smoking Cessation Counseling (BEHAVIORAL), Cognitive-Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01277887?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01277887's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia